- Home
- KW vs ORIC Comparison
KW vs ORIC Comparison
Compare KW & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KW
- ORIC
- Stock Information
- Founded
- KW 1977
- ORIC 2014
- Country
- KW United States
- ORIC United States
- Employees
- KW N/A
- ORIC N/A
- Industry
- KW Real Estate
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- KW Finance
- ORIC Health Care
- Exchange
- KW Nasdaq
- ORIC Nasdaq
- Market Cap
- KW 1.1B
- ORIC 974.1M
- IPO Year
- KW 1992
- ORIC 2020
- Fundamental
- Price
- KW $8.87
- ORIC $10.73
- Analyst Decision
- KW
- ORIC Strong Buy
- Analyst Count
- KW 0
- ORIC 10
- Target Price
- KW N/A
- ORIC $17.33
- AVG Volume (30 Days)
- KW 686.4K
- ORIC 903.1K
- Earning Date
- KW 11-05-2025
- ORIC 11-11-2025
- Dividend Yield
- KW 5.56%
- ORIC N/A
- EPS Growth
- KW N/A
- ORIC N/A
- EPS
- KW N/A
- ORIC N/A
- Revenue
- KW $531,500,000.00
- ORIC N/A
- Revenue This Year
- KW $30.64
- ORIC N/A
- Revenue Next Year
- KW $3.01
- ORIC N/A
- P/E Ratio
- KW N/A
- ORIC N/A
- Revenue Growth
- KW 6.96
- ORIC N/A
- 52 Week Low
- KW $5.98
- ORIC $3.90
- 52 Week High
- KW $11.88
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- KW 59.21
- ORIC 55.95
- Support Level
- KW $8.55
- ORIC $10.37
- Resistance Level
- KW $9.15
- ORIC $11.16
- Average True Range (ATR)
- KW 0.23
- ORIC 0.54
- MACD
- KW -0.05
- ORIC 0.03
- Stochastic Oscillator
- KW 56.76
- ORIC 67.14
About KW Kennedy-Wilson Holdings Inc.
Kennedy-Wilson Holdings Inc is a real estate investment company that owns, operates, and invests in real estate both on its own and through its investment management platform. The Company focuses on multifamily and office properties, as well as industrial and debt investments. It has two business segments; the Consolidated Portfolio includes investment activities that involve ownership of multifamily units, office, retail and industrial space, and one hotel, and The Co-Investment Portfolio segment consists of investments the Company makes with partners in which it receives fees, performance allocations that it earns on its fee-bearing capital and distributions and profits from its ownership interest in the underlying operations of its co-investments.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.